Page 35 - Stephens Drive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioAtla Announces Pricing of Initial Public Offering News provided by Share this article Share this article SAN DIEGO, Dec. 15, 2020 /PRNewswire/ -- BioAtla, Inc. (Nasdaq: BCAB), a clinical-stage biopharmaceutical company developing a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer, today announced the pricing of its initial public offering of 10,500,000 shares of common stock at a public offering price of $18.00 per share. All of the shares of common stock are being offered by BioAtla. The shares of common stock are expected to...

/PRNewswire/ -- Decarbonization Plus Acquisition Corporation (NASDAQ: DCRBU) (the "Company") announced that, commencing December 14, 2020, holders of the units...

Posted on 185 Frazier Healthcare Partners’ special purpose acquisition corporation, Frazier Lifesciences Acquisition Corporation, announced the pricing of its initial public offering of 12,000,000 units, at a price to the public of $10.00 per unit, for aggregate gross proceeds of $120,000,000. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share. The units are expected to begin trading on the Nasdaq Cap...